Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

20.0%

2 terminated/withdrawn out of 10 trials

Success Rate

77.8%

-8.7% vs industry average

Late-Stage Pipeline

40%

4 trials in Phase 3/4

Results Transparency

14%

1 of 7 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 4

3(42.9%)

N/A

2(28.6%)

Phase 3

1(14.3%)

Phase 2

1(14.3%)

7Total

Phase 4(3)

N/A(2)

Phase 3(1)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT02955485Terminated

A Prediction Model for Chronic Ankle Instability

Role: collaborator

NCT02011958Phase 3Completed

Efficacy Trial of Ambisome Given Alone and Ambisome Given in Combination With Miltefosine for the Treatment of VL HIV Positive Ethiopian Patients.

Role: collaborator

NCT02253121Phase 4Completed

Glucose Control During Glucocorticoid Therapy in Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Role: lead

NCT03330756Not ApplicableUnknown

The Effects of the Laparoscopic Roux-en-Y Gastric Bypass and Laparoscopic Mini Gastric Bypass on the Remission of Type II Diabetes Mellitus

Role: lead

NCT02095925Completed

Cohort Study to Identify Cancer Patients at High Risk of Venous Thromboembolism

Role: collaborator

NCT01912495Phase 2Completed

Dutch Acute HCV in HIV Study (DAHHS)

Role: collaborator

NCT02155374Phase 4Completed

Glucose Control for Glucocorticoid Induced Hyperglycemia During Chemotherapy

Role: lead

NCT01139489Not ApplicableCompleted

Safety and Efficacy of Procalcitonin Guided Antibiotic Therapy in Adult Intensive Care Units (ICU's)

Role: collaborator

NCT00875368Phase 4Completed

Maraviroc Immune Recovery Study

Role: collaborator

NCT01088334Terminated

Mortality Due to Malignancy in Patients With Idiopathic Venous Thromboembolism

Role: lead

All 10 trials loaded